James Hindman

Mr. James M.
Hindman is an Independent Director at Urovant Sciences Ltd., an Independent Director at Accuray, Inc. and a Treasurer at Vicept Therapeutics, Inc. He is on the Board of Directors at Urovant Sciences Ltd., Accuray, Inc., Loyola Marymount University, NeuroSigma, Inc. and Aatru Medical LLC.
Mr. Hindman was previously employed as an Independent Director by Millendo Therapeutics, Inc., an Independent Director by Sienna Biopharmaceuticals, Inc., a President & Director by Allergan Foundation, and a Head-Investor Relations by Allergan, Inc. He also served on the board at Amolyt Pharma SAS, Urovant Sciences, Inc. and Millendo Therapeutics US, Inc. He received his undergraduate degree from Loyola Marymount University and an MBA from Pepperdine University.